Us Bancorp \De\ Tg Therapeutics, Inc. Transaction History

Us Bancorp \De\

$77.3 Billion
Q3 2024

A detailed history of Us Bancorp \De\ transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 4,804 shares of TGTX stock, worth $144,360. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,804

Previous 4,828 0.5%

Holding current value

$144,360

Previous $85,000 31.76%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$17.21 - $25.28 $413 - $606	-24 Reduced 0.5%	4,804 $112,000
Q2 2024 Aug 06, 2024	SELL	$13.32 - $19.19 $18,674 - $26,904	-1,402 Reduced 22.5%	4,828 $85,000
Q1 2024 May 07, 2024	BUY	$13.02 - $21.3 $14,881 - $24,345	1,143 Added 22.47%	6,230 $94,000
Q4 2023 Feb 09, 2024	BUY	$6.68 - $18.81 $31,062 - $87,466	4,650 Added 1064.07%	5,087 $86,000
Q3 2023 Nov 03, 2023	SELL	$8.36 - $26.5 $77,547 - $245,814	-9,276 Reduced 95.5%	437 $3,000
Q2 2023 Aug 09, 2023	BUY	$15.48 - $35.0 $113,979 - $257,705	7,363 Added 313.32%	9,713 $241,000
Q1 2023 May 09, 2023	SELL	$10.23 - $19.34 $208,160 - $393,530	-20,348 Reduced 89.65%	2,350 $35,000
Q4 2022 Feb 13, 2023	BUY	$5.01 - $11.83 $97,354 - $229,880	19,432 Added 594.98%	22,698 $268,000
Q3 2022 Oct 27, 2022	BUY	$4.57 - $8.4 $9,039 - $16,615	1,978 Added 153.57%	3,266 $19,000
Q2 2022 Aug 01, 2022	SELL	$3.74 - $10.66 $635 - $1,812	-170 Reduced 11.66%	1,288 $5,000
Q1 2022 May 11, 2022	BUY	$7.81 - $20.45 $8,387 - $21,963	1,074 Added 279.69%	1,458 $14,000
Q4 2021 Feb 11, 2022	SELL	$15.2 - $35.51 $577 - $1,349	-38 Reduced 9.0%	384 $7,000
Q3 2021 Nov 10, 2021	SELL	$21.78 - $40.45 $285,971 - $531,108	-13,130 Reduced 96.89%	422 $14,000
Q2 2021 Aug 05, 2021	BUY	$32.5 - $48.96 $2,860 - $4,308	88 Added 0.65%	13,552 $525,000
Q1 2021 Apr 28, 2021	BUY	$41.61 - $54.3 $29,251 - $38,172	703 Added 5.51%	13,464 $649,000
Q4 2020 Feb 04, 2021	BUY	$25.27 - $54.9 $322,470 - $700,578	12,761 New	12,761 $664,000

Others Institutions Holding TGTX

# of Institutions

337

Shares Held

87.7M

Call Options Held

2.35M

Put Options Held

1.7M

View Full List

About TG THERAPEUTICS, INC.

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.37B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

More about TGTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account